Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Ectodermal dysplasia-intellectual disability-central nervous system malformation syndrome is a rare, multiple developmental anomalies syndrome characterized by the triad of ectodermal dysplasia (mostly hypohidrotic with dry skin and reduced sweating and sparse, fair scalp hair, eyebrows and eyelashes), severe intellectual disability and variable central nervous system anomalies (cerebellar hypoplasia, dilatation of ventricles, corpus callosum agenesis, Dandy-Walker malformation). Distinct craniofacial dysmorphism with macrocephaly, frontal bossing, midfacial hypoplasia and high arched or cleft palate, as well as cryptorchidism, feeding difficulties and hypotonia, are associated. There have been no further descriptions in the literature since 1998.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for ectodermal dysplasia-intellectual disability-central nervous system malformation syndrome.
11 publications have been identified in PubMed for ectodermal dysplasia-intellectual disability-central nervous system malformation syndrome. Research spans Review / Meta-Analysis (55%), Case Report / Case Series (27%), and Basic Science / Preclinical (9%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 6 |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 7:43 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Patient case studies | 3 | 27% |
Laboratory research | 1 | 9% |
Disease patterns and progression | 1 | 9% |
Bilgeç N (2026). [PMID: 40416445](https://pubmed.ncbi.nlm.nih.gov/40416445/). *Mol Syndromol*. [Review / Meta-Analysis]
Gaudioso F (2025). [PMID: 41562894](https://pubmed.ncbi.nlm.nih.gov/41562894/). *Med Sci (Basel)*. [Review / Meta-Analysis]
Russo M (2025). [PMID: 40038803](https://pubmed.ncbi.nlm.nih.gov/40038803/). *Ital J Pediatr*. [Review / Meta-Analysis]
Kimura-Yoshida C (2025). [PMID: 40761126](https://pubmed.ncbi.nlm.nih.gov/40761126/). *Development*. [Basic Science / Preclinical]
Hori I (2024). [PMID: 39164139](https://pubmed.ncbi.nlm.nih.gov/39164139/). *Brain Dev*. [Epidemiology / Natural History]
Sreenivasan V (2024). [PMID: 38659257](https://pubmed.ncbi.nlm.nih.gov/38659257/). *Paediatr Int Child Health*. [Case Report / Case Series]
Leduc F (2024). [PMID: 38677542](https://pubmed.ncbi.nlm.nih.gov/38677542/). *Eur J Med Genet*. [Review / Meta-Analysis]
Akalın A (2024). [PMID: 38841326](https://pubmed.ncbi.nlm.nih.gov/38841326/). *Mol Syndromol*. [Case Report / Case Series]
Elrod J (2024). [PMID: 38429208](https://pubmed.ncbi.nlm.nih.gov/38429208/). *Pediatr Neonatol*. [Case Report / Case Series]
Lopes FCPS (2024). [PMID: 39622606](https://pubmed.ncbi.nlm.nih.gov/39622606/). *Semin Pediatr Neurol*. [Review / Meta-Analysis]